Javier G. Viguera
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study.
Journal: Frontiers in neurology
Published: April 15, 2024
Observational Retrospective Study in Patients Treated with Galcanezumab as Preventive Treatment for Migraine: The ORYGAM Study.
Journal: Pain and therapy
Published: December 11, 2023
Increase in the number of adjuvant radiotherapy treatments in breast cancer patients in 2022: effect of COVID-19 pandemic?
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 29, 2023
MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention.
Journal: The journal of headache and pain
Published: February 28, 2021
Evaluation of the concomitant use of oral preventive treatments and onabotulinumtoxinA in chronic migraine: the PREVENBOX study.
Journal: European journal of neurology
Published: April 13, 2020
Calcitonin gene-related peptide in migraine: from pathophysiology to treatment.
Journal: Neurologia
Published: December 20, 2018
Calcitonin gene-related peptide in migraine: from pathophysiology to treatment.
Journal: Neurologia
Published: December 20, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026